Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Mitchell
Conference
AASP Northeast Trade Show
Visit Us at the Exhibit Booth Northeast is an eve
Workers' Comp
White Paper
Substance Misuse Recovery Network
Specialty Networks Play a Key Role in Fighting Opioid Misuse For all the progress our nation has made in reducing opioid prescriptions, m
Mitchell
News Release
In a Hazy Election, Marijuana Is a Clear Winner
As ballots continue to be counted around the country, with some races still too close to call, voters were much more certain on their support for m
Mitchell
News Release
Evzio Naloxone Auto-Injectors Discontinued
Kaleo, the makers of Evzio, have recently discontinued the prod
Workers' Comp
News Release
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an
Workers' Comp
Blog
Look for a Broken Spirit, Not Just a Broken Bone
As featured on the workcompwire.com blog, this piece was contributed by Tammy Bradly, Vice President, Clinical Product Develo